Moreover, glucose metabolism is significantly decreased in AD patients 10 years before the appearance of clinical symptoms [5], with reductions of Glut-1 and Glut-3 in AD patients’ brains [71, 72]. Here, SLC2A3 is linked to Alzheimer disease.